Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07282769
PHASE2
Semaglutide (Wegovy) Treatment for Trichotillomania
Sponsor: University of Chicago
View on ClinicalTrials.gov
Summary
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
Official title: Once Weekly Semaglutide Treatment of Trichotillomania: An Open-Label Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-02
Completion Date
2027-02
Last Updated
2025-12-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Semaglutide
All participants in the study will receive semaglutide (Wegovy).